[文献资料]参 考 文 献

Phase Ⅱ b multicenter trial of vorinostat in patients with persistent，progressive，or treatment refractory cutaneous T-cell lymphoma .Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with tr ......